BIKTARVY (bictegravir/emtricitabine/TAF) Patient Assistance Program
Don’t let the high cost of brand single-tablet HIV regimen disrupt your treatment. We help eligible patients access Biktarvy (bictegravir/emtricitabine/TAF) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is FDA-approved as a once-daily, single-tablet HIV-1 regimen for treatment-naïve and virologically suppressed adults and pediatric patients ≥14 kg. Most widely prescribed HIV regimen in U.S. — preferred first-line per HIV guidelines.
- Without assistance, Biktarvy costs commonly run approximately $3,800–$4,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Biktarvy for a flat $69.95 per month.
- No generic Biktarvy. Other once-daily INSTI-based single-tablet regimens: Triumeq (DTG/ABC/3TC — generic ABC/3TC available; needs HLA-B*5701 testing), Dovato (DTG/3TC two-drug), Genvoya (EVG/c/FTC/TAF). State ADAP programs typically cover HIV medications regardless of cost.
What Is Biktarvy Prescription Assistance Program?
Biktarvy PAP for HIV patients.
Eligibility, HIV provider coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Biktarvy $3,800–$4,200/month:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$4,100 | Save substantially |
| CVS Pharmacy | ~$4,200 | Save substantially |
| Walmart | ~$3,900 | Save substantially |
| Costco | ~$3,850 | Save substantially |
State ADAP | Often free | ADAP for eligible |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Biktarvy Prescription Program?
PAP at no cost. State ADAP programs typically cover HIV medications regardless of cost for eligible patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Biktarvy:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,800–$4,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Biktarvy assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Biktarvy Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Biktarvy:
Biktarvy is preferred first-line single-tablet HIV regimen. Combines bictegravir (potent INSTI with high resistance barrier), emtricitabine (FTC, NRTI), and tenofovir alafenamide (TAF — less kidney/bone toxicity than TDF).
How Biktarvy Works:
INSTI blocks HIV integrase preventing integration into host DNA. NRTI backbone (FTC + TAF) blocks reverse transcriptase.
Once-daily small tablet (smallest INSTI STR). No HLA testing needed (unlike abacavir-containing Triumeq). High resistance barrier — limited cross-resistance issues. Excellent tolerability — first-line per current HIV guidelines for most treatment-naive patients.
Form and use:
Biktarvy one tablet once daily with or without food.
Generic availability:
No generic Biktarvy. Other INSTI-based STRs: Triumeq (DTG/ABC/3TC — generic backbone available), Dovato (DTG/3TC two-drug — for select patients without resistance), Genvoya (older EVG-based). State ADAP programs typically cover regardless of cost.
Warnings:
HBV exacerbation if discontinued in HBV co-infection (test before starting), immune reconstitution syndrome, lactic acidosis (rare), drug interactions (cation-containing antacids/supplements — separate; rifampin contraindicated; rifabutin avoid).
FAQ (Frequently Asked Questions)
Cost?
$3,800–$4,200/month. PAP and ADAP typically cover.
Why Biktarvy first-line?
Highest barrier to resistance among single-tablet regimens. Smallest pill. No HLA testing needed. Excellent tolerability. Once-daily small tablet.
ADAP?
AIDS Drug Assistance Program — state-administered, federally funded. Covers HIV medications for eligible low-income uninsured/underinsured patients. Income limits vary by state. Contact local HIV organization.
HBV co-infection?
Biktarvy FTC + TAF active against HBV. Don’t discontinue without HBV monitoring — risk of HBV flare.
Denied?
PAP, ADAP, manufacturer copay program, foundation aid. HIV medications widely supported.
Take Control of Your Medication Costs
PAP, ADAP, foundations widely support HIV care access. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.